Editor’s note Moderna’s mRNA-based RSV vaccine is effective in preventing RSV-associated lower-respiratory tract disease in adults aged 60 an older, according to randomized phase II-III trial results published December 14 in The New England Journal of Medicine. Results also confirmed the safety of a single dose of the vaccine, researchers…

Read More

Editor's Note A new nasal vaccine in development by Griffith University’s Institute for Glycomics in Australia could provide long-term protection against the deadly bacteria Streptococcus A (Strep A), Griffith University's Griffith News October 5 reports. Strep A causes 700 million human infections each year, and there are more than 500,000…

Read More

Editor's Note An experimental vaccine designed by researchers at University of Southern California has been shown to prevent serious infections from drug-resistant pathogens, according to an October 2023 study published by Science Translational Medicine. In this study, titled "A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens," the…

Read More

Editor's Note On October 18, the White House released the “National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security” (the strategy), Becker's Hospital Review October 19 reports. The strategy includes the objective to create enough vaccines for the US population within…

Read More

Editor's Note This study by researchers in South Korea analyzes a COVID-19 outbreak caused by vaccine breakthrough infections in a hospital where 91.9% of healthcare workers were vaccinated. In addition, it was mandatory that all healthcare workers and caregivers wear masks or respirators at all times except when eating. During…

Read More